SCHEMBL8501972

SCHEMBL8501972

Fc1cccc(-c2cnc3cccc(C=Cc4ccccc4)c3c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 5/20 0.47
MAP4K4 O95819 1/20 0.46
PIK3CD O00329 1/20 0.42
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
MTOR P42345 1/20 0.42
PIK3CG P48736 1/20 0.42
PDGFRB P09619 3/20 0.42
PDGFRA P16234 3/20 0.42
TUBB4A P04350 2/20 0.41
TUBB P07437 2/20 0.41
TUBA3C P0DPH7 2/20 0.41
TUBA1B P68363 2/20 0.41
TUBA4A P68366 2/20 0.41
TUBB4B P68371 2/20 0.41
TUBB3 Q13509 2/20 0.41
TUBB2A Q13885 2/20 0.41
TUBB8 Q3ZCM7 2/20 0.41
TUBA3E Q6PEY2 2/20 0.41
TUBA1A Q71U36 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8887518 1.00 NFE2L2 (0.47) NFE2L2MAP4K4PIK3CDPIK3CAPIK3CB
SCHEMBL8526328 0.80 NFE2L2 (0.53) NFE2L2PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL8526330 0.80 NFE2L2 (0.53) NFE2L2PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL8889043 0.76 RELA (0.47) MAP4K4PIK3CAMTORPDGFRBPDGFRA
SCHEMBL8889052 0.75 MAP4K4 (0.42) MAP4K4PDGFRBPDGFRANT5ESSTR2
SCHEMBL8889037 0.75 MAP4K4 (0.42) MAP4K4PDGFRBPDGFRANT5ESSTR2
SCHEMBL2331739 0.75 CNR1 (0.58) NFE2L2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2331742 0.75 CNR1 (0.58) NFE2L2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL7283402 0.73 MET (0.50) MAP4K4PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL8867498 0.73 MAPK10 (0.50) MAP4K4PIK3CDPIK3CAPIK3CBMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US claimed
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 US disclosed
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US disclosed